Abstract. Platelet-derived growth factor (PDGF) acts as a regulator in cancer development and progression. We investigated whether single nucleotide polymorphisms (SNPs) of platelet-derived growth factor receptor α polypeptide (PDGFRA) and platelet-derived growth factor receptor β polypeptide (PDGFRB) genes are associated with papillary thyroid cancer (PTC) in a Korean population. Two promoter SNPs (rs6554162, -1309A/G and rs1800812, -635G/T) of PDGFRA and one promoter SNP (rs3828610, -202A/C) of PDGFRB were genotyped using direct sequencing in 93 PTCs and 212 controls. Genetic data were analyzed using the SNPAnalyzer Pro, SNPStats and Haploview programs. Two promoter SNPs (rs6554162 and rs1800812) in PDGFRA revealed significant differences between PTC and controls (for rs6554162, p=0.0018 in the codominant model and p=0.0005 in the dominant model; for rs1800812, p=0.016 in the codominant model and p=0.007 in the dominant model). In the analysis of allele frequency, we also found that the A allele of rs6554162 (p=0.004) and the T allele of rs1800812 (p=0.029) were associated with PTC. Additionally, by haplotype analysis, the GG and AT haplotypes consisting of rs6554162 and rs1800812 were associated with PTC (GG, p=0.0033; AT, p=0.0270). However, rs3828610 in PDGFRB showed no significant difference between PTC and controls. The results suggest that PDGFRA promoter SNPs (rs6554162 and rs1800812) may be associated with the risk of PTC.
Introduction
Thyroid cancers, well known as the most common endocrine tumors in humans, have shown an increased prevalence during the past three decades (1, 2) . They are classified pathologically as papillary, follicular, anaplastic and medullary carcinomas (2) . Papillary thyroid cancer (PTC) is the most common thyroid cancer, accounting for more than 70% of cases (3) . PTC is a high cure cancer with a 10-year survival rate of 80-90% compared with other types of thyroid cancers (2) . In previous studies, PTC appears to have higher heritability compared to other cancers (4, 5) .
Platelet-derived growth factor (PDGF)/PDGF receptor (PDGFR) system contains two receptors [platelet-derived growth factor receptor α polypeptide (PDGFRA) and plateletderived growth factor receptor β polypeptide (PDGFRB)] and four ligands (PDGFA, B, C and D) (6, 7) . Expression of PDGFRs and PDGFs have crucial functions during embryogenesis, in particular in the development of connective tissue of the kidneys, blood vessels, lungs and central nervous system (7) . Previous research reveals that PDGF contributes to cancer development and its progression through both autocrine and paracrine signaling mechanisms (8) . Chen et al (9) showed that mRNA and protein expression of PDGFA and PDGFRA was increased in thyroid carcinoma cell lines compared to benign tissues of thyroid nodular hyperplasia. These findings indicate that the expression of PDGFRs plays a crucial role in the carcinogenesis of thyroid cells.
Genetic influence is known as the established risk factor for PTC and several studies have investigated the genetic association between PTC and candidate genes (10-12). Ozgen et al (10) reported that the -174 G/C single nucleotide polymorphism (SNP) of interleukin-6 plays a role in the risk of thyroid cancer in Turkish patients. Lemos et al (11) demonstrated that the polymorphism of cytochrome P450 2D6 (CYP2D6) was associated with PTC. The G allele of rs3805435 or the T allele of rs3828599 in glutathione peroxidase 3 may exert a protective effect for differentiated thyroid cancer in an elderly population, whereas the C allele of rs8177412 confers an increased risk effect (12 T allele in the PTC group (9.7%) was lower than that of the control group (16.5%). However, rs3828610 of PDGFRB was not associated with PTC (Table II) . We also performed a further analysis according to the clinical symptoms of PTC (cancer size, number of cancers, location of cancer, extrathyroidal invasion and cervical lymph node metastasis). However, we did not find any association with the tested SNPs of PDGFRA and PDGFEB (data not shown). As shown in Fig. 1 , the LD block was constructed between rs6554162 and rs1800812 of PDGFRA (D'≥0.95, r 2 ≥0.8) by the Gabriel method (15) . In the analysis of haplotypes, GG and PDGFRA, platelet-derived growth factor receptor α polypeptide; PDGFRB, platelet-derived growth factor receptor β polypeptide; SNP, single nucleotide polymorphism; PTC, papillary thyroid cancer; OR, odds ratio; 95% CI, 95% confidence interval; p-values were from logistic regression analysis with the codominant, dominant and recessive models controlling age and gender as covariates. AT were associated with PTC (GG, Chi-square test 8.623, p=0.0033; AT, Chi-square test 4.888, p=0.0270) (Table III) .
Discussion
In this study, two promoter SNPs (rs6554162 and rs1800812) of PDGFRA were associated with PTC in a Korean population.
In particular, we found that the frequencies of the A allele of rs6554162 and the T allele of rs1800812 were decreased in the PTC group, compared to the control group. Moreover, the GG and AT haplotypes consisting of rs6554162 and rs1800812 were also associated with PTC, respectively. However, rs3828610 of PDGFRB was not associated with PTC. Several researchers investigated the genetic association between polymorphisms of PDGFRA or PDGFRB and several diseases (16) (17) (18) . Wu et al (16) reported that rs1800810 SNP of PDGFRA was associated with the severity and allergic status of childhood asthma. De Bustos et al (17) revealed that a PDGFRA promoter polymorphism, which disrupts the binding of ZNF148, was associated with primitive neuroectodermal tumors and ependymomas. Kim et al (18) reported that the promoter SNPs (rs3756314, rs3756312 and rs3756311) of PDGFRB were associated with schizophrenia. Although we excluded above the promoter SNPs of PDGFRA and PDGFRB according to the data of dbSNP BUILD 135, two promoter SNPs (rs6554162, -1309A/G and rs1800812, -635G/T) selected in the present study were also associated with PTC. The results raise the possibility that PDGFRA promoter SNPs may contribute to the development of PTC.
To find whether the promoter SNPs affect transcription factors, the online program AliBaba 2.1 (http://www.generegulation.com/pub/programs/alibaba2) was used. At the rs6554162 SNP site in PDGFRA, the G-containing sequences bind with USF transcription factor, but USF disappears in the A-containing sequences. At the rs1800812 SNP site in PDGFRA, the G-containing sequences interact with NF1 and YY1, but these transcription factors disappear in the T-containing sequences. Assuming the change of transcript factors according to variants of SNPs, these promoter SNPs may influence gene and protein expression of PDGFRA. In addition, we compared genotype frequencies of rs6554162, rs1800812 and rs3828610 in other populations. In conclusion, we found that two promoter SNPs (rs6554162 and rs1800812) of PDGFRA were associated with PTC. Our results indicate that PDGFRA may contribute to the susceptibility of PTC in a Korean population. Further studies in different populations or other SNPs of PDGFRA are required.
